Abstract
Local injection of BTX-A is now used for a wide range of neuropathic voiding dysfunctions, including neurogenic detrusor overactivity, detrusor-sphincter dyssynergia, and urge incontinence. 1 Leippold T. Reitz A. Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol. 2003; 44: 165-174 Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar Intravesical injection of botulinum toxin type A: Management of neuropathic bladder and bowel dysfunction in children with myelomeningoceleUrologyVol. 68Issue 5PreviewTo evaluate the efficacy of botulinum toxin A in the treatment of children with detrusor hyperreflexia caused by myelomeningocele and the effects of this treatment on neuropathic bladder and bowel dysfunction. Full-Text PDF
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call